Acute exacerbation in interstitial lung disease.

Autor: Alhamad EH; Department of Medicine, Division of Pulmonary Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia., Cal JG; Department of Medicine, Division of Pulmonary Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia., Alrajhi NN; Department of Medicine, Division of Pulmonary Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia., AlBoukai AA; Department of Radiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Jazyk: angličtina
Zdroj: Annals of thoracic medicine [Ann Thorac Med] 2021 Apr-Jun; Vol. 16 (2), pp. 178-187. Date of Electronic Publication: 2021 Apr 17.
DOI: 10.4103/atm.atm_14_21
Abstrakt: Background: Information regarding acute exacerbation (AE) in patients with interstitial lung disease (ILD) is limited.
Objectives: The objective of the study was to elucidate the clinical features and outcome of AE among ILD patients.
Methods: We retrospectively analyzed the data of 667 consecutive ILD (nonidiopathic pulmonary fibrosis [IPF] ILD, n = 463; IPF, n = 204) patients. ILD patients meeting the 2016 definition of AE-IPF were identified. Information analyzed included pulmonary function tests, 6-min walk tests, and right heart catheterization data, among others. Cox regression models were used to identify independent predictors of survival.
Results: AE was identified in non-IPF ILD ( n = 113) and IPF ( n = 74). Compared with AE-IPF patients, non-IPF ILD patients with AE were of younger age, predominantly women, and primarily nonsmokers (all, P < 0.0001). The estimated survival probabilities at 1, 3, and 5 years were 88%, 75%, and 70%, respectively, in the ILD without AE group; 80%, 57%, and 50%, respectively, in the non-IPF ILD with AE group; and 53%, 38%, and 28%, respectively, in the AE-IPF group ( P < 0.0001 by log-rank analysis). Age, body mass index, IPF diagnosis, AE, diffusion capacity of the lung for carbon monoxide <35% predicted, 6-min walk distance <300 meters, and cardiac index were independent predictors of survival in the ILD cohort.
Conclusions: Non-IPF ILD patients with AE have distinct clinical features compared to AE-IPF patients. Importantly, AE is one of many independent risk factors associated with worsened outcomes regardless of the underlying ILD type.
Competing Interests: There are no conflicts of interest.
(Copyright: © 2021 Annals of Thoracic Medicine.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje